NewcelX Ltd. (NCEL) stock
NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.54−0.15 (-5.58%)
Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –
NewcelX pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
NewcelX's pe ratio was 1.3× on Nov 11, 2026, against 1.7× a year earlier. Over the last 3 years it ranged from 0.8× to 77.7×, with a median of 7.5×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.3× | +0.5 |
| 2025 | Dec 31, 2025 | 0.8× | −17.9 |
| 2024 | Dec 31, 2024 | 18.7× | – |
See a number that looks wrong?